Patents, Publications, and Research
Patents
US Patent # 9,168,002 – October 27, 2015
A device and method for real time simultaneous measurement of radiation at specific parts of your body. Understanding cumulative radiation exposure in people undergoing ionizing radiation for diagnostics and medical treatment is essential towards reducing secondary tumors from primary radiation therapy.
US Provisional Patent Application No. 62/370,092 – September 7, 2016
Mobile Device Health Monitoring
Cancergraph Symptom and Side Effect recording and reporting mobile app
Patent pending on various aspects and algorithms
Publications and Abstracts Largely or Entirely Based on Malecare Community
Poster Presentation and Abstract ASCO-GU 2016: Understanding prostate cancer survivorship relative to co-habitation.
Mitteldorf, D. ..J Clin Oncol 34, 2016 (suppl 2S; abstr 253)
Book Chapters:
Mitteldorf, D. 2005 “Psychotherapy with Gay Prostate Cancer Patients”
In G. Perlman, J. Drescher (eds) A GAY MAN’S GUIDE TO PROSTATE CANCER
New York: Haworth Press
Mitteldorf, D. 2013 “Coming out to Doctors”
In G. Perlman (ed) WHAT EVERY GAY MAN NEEDS TO KNOW ABOUT PROSTATE CANCER
New York: Magnus Books.
Mitteldorf, D. 2013 “What I have learned from working with Gay Men with Prostate Cancer”
In G. Perlman (ed) WHAT EVERY GAY MAN NEEDS TO KNOW ABOUT PROSTATE CANCER
New York: Magnus Books.
Mitteldorf, D. (2017) Malecare: Twenty years of innovation and service to gay and bisexual men and transgender women with prostate cancer. In J. Ussher, J. Perz, B.R.S. Rosser (eds). Gay and Bisexual Men Living with Prostate Cancer: From Diagnosis to Recovery. New York, NY: Harrington Park Press
Mitteldorf, D., Latini, D., Perlman, G. (2019) Cancer in Men and Transgender Women In J. Schneider, V. Silenzio, L. Erickson-Schroth (eds) .The GLMA Handbook on LGBT Health [2 volumes] Santa Bargara, California: Praeger
Journals:
Mitteldorf, D. (2003) Fertility and cancer patients. Journal of Oncolistics Vol 3
Mitteldorf, D. (2005) Psychotherapy with Gay Prostate Cancer Patients. Journal of Gay & Lesbian Psychotherapy Vol 9 (1-2)
Mitteldorf, D. (2010) A review of “Homophobia: The State of Sexual Bigotry Today” Journal of Gay and Lesbian Mental Health Vol 14 (2)
Mitteldorf, D., (2016) Understand prostate cancer survivorship relative to co-habitation. Journal of Clinical Oncology Vol 34 (2)
Mitteldorf, D. (2016) Treatment disparities between heterosexual and gay and bisexual men diagnosed with prostate cancer. Journal of Clinical Oncology Vol 34 (15)
Mitteldorf, D., Nelms, J., (2018) Are prostate cancer treatments correlated to sleep distress? Journal of Clinical Oncology Vol 36 (6)
Abstract ASCO Annual Meeting 2016: Treatment disparities between heterosexual and gay and bisexual men diagnosed with prostate cancer.
Mitteldorf, D. ..J Clin Oncol 34, 2016 (suppl; abstr e16548)
ORAL PRESENTATIONS AND POSTERS:
Mitteldorf, D., (2007) Unique Treatment Issues for Gay Men Diagnosed with Prostate Cancer
Department of Defense IMPACT Prostate Cancer Conference: Atlanta Georgia
Mitteldorf, D., Cancer Risks in the LGBT Community (2007) Diversity 2007: Dallas, Texas
Mitteldorf, D., (2009) African Americans and Prostate Cancer American Cancer Society: New York
Mitteldorf, D., (2010) LGBT Patient Accrual in Clinical Trials National Cancer Institute: Washington DC
Mitteldorf, D., (2010) Lesbian, Gay, Bisexual and Transgender Cancer Survivorship American Cancer Society: New York
Mitteldorf, D., (2012) Connecting with Your Doctor Cancer Conference Memorial Sloan Kettering Cancer Center: New York
Mitteldorf, D., (2014) Public Private Partnerships in Oncology Sachs Biotech Forum-New York Academy of Sciences: New York
Mitteldorf, D., (2015) Issues Faced by LGBT Cancer Survivors World Cancer Congress Union for International Cancer Control Montreal Canada
Mitteldorf, D., (2015) Psycho-Social Benefits of Gay Men with Prostate Cancer Support Groups Department of Defense IMPACT Prostate Cancer Conference: Atlanta Georgia
Mitteldorf, D., (2015) How Patients Value Quality of Life Sachs Biotech Forum-New York Academy of Sciences: New York
Mitteldorf, D., LGBTQ Couples and Value-Based Care National Comprehensive Cancer Network (NCCN) Washington, DC, January 2020
Mitteldorf, D., Caring for the LGBT Couple Facing a Cancer Diagnosis Society of Sexual Medicine Annual Conference Miami, Florida, October 2022
Mitteldorf, D., LGBTQ Couples and Cancer National Comprehensive Cancer Network (NCCN) Washington, DC, December 2022
Research Projects
Molecular Oncology Project
Marketing new tests and diagnostics requires understanding the semiotics of patient appreciation of novel health opportunities. Our first phase involved accruing 200 prostate cancer patients for a free in-depth molecular oncology testing and consultation, which Malecare conducted in collaboration with Massive Bio. During phase two, Malecare conducted in-depth interviews with these patients regarding their experience with our molecular oncology testing and consultation. From these interviews, Malecare will discover how to communicate the value of new testing and consultant opportunities to prostate cancer patients.
Facing Cancer Alone
Malecare conducted the first large scale survey (N=1799) to understand what if any benefits are accrued by co-habitation to treatment compliance, quality of life and psycho-social stability for men diagnosed with prostate cancer. This research will be presented during ASCO-GU January 2016.
My Prostate Cancer Experience
Malecare completed a N=1268 survey of men diagnosed with prostate cancer, exploring their day to day experience managing side effects, their experience specific advanced stage treatments and their relationship with their Doctors, across the continuum of their treatment experience. This survey also discovers significant disparities in experience across the age of diagnosis, race, gender and sexual identity.
Better Ask
Malecare’s research study (N=622) investigated the quality of the patient-doctor consultation during prostate cancer treatment. We discovered how patients and doctors ask and respond to questions during their prostate cancer consultation. We also investigated how patients spend their “waiting room” time.
The Restore Study
Funded by the National Cancer Institute at NIH, Malecare, in collaboration with the University of Minnesota, investigated how prostate cancer treatment affects gay and bisexual men, partners, and family and friends. The study focused on how different treatments affect sexual functioning, gay sex, and gay relationships. Completed in November 2015, we achieved the largest and most comprehensive survey of gay and bisexual men with prostate cancer.
Twice As Many
Malecare interviewed men of African Descent diagnosed with prostate cancer and spouses to understand the psycho-social dimensions regarding prostate cancer killing African American men at 2.4 times the rate as it kills Caucasian men. Malecare developed new methods of messaging to African American men diagnosed with prostate cancer and dispelled several myths about African American men and clinical trial accrual.
Using Social Media
Malecare surveyed 634 men diagnosed with prostate cancer to understand how they use and value information derived from social media.